<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03174418</url>
  </required_header>
  <id_info>
    <org_study_id>01012017</org_study_id>
    <nct_id>NCT03174418</nct_id>
  </id_info>
  <brief_title>Fluid-dynamics in Bifurcation PCI</brief_title>
  <acronym>FORECAST</acronym>
  <official_title>A Multicentre Prospective Study on the Role of Fluid Dynamics OCT-based REconstruction of Coronary Atherosclerosis in bifurcationS to Predict ouTcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <brief_summary>
    <textblock>
      Investigator-initiated, international, multicentre, observational study with two cohorts.&#xD;
&#xD;
      The two study cohorts will be:&#xD;
&#xD;
      Cohort A: to understand if the local blood flow patterns (associated with low WSS), as&#xD;
      evaluated by computational fluid dynamic tools from combined angiographic and OCT invasive&#xD;
      images, may better predict the clinical outcome of patients with bifurcated coronary lesions&#xD;
      treated by PCI.&#xD;
&#xD;
      Cohort B: to understand if the local blood flow patterns (associated with low WSS), as&#xD;
      evaluated by computational fluid dynamic tools from combined angiographic and OCT invasive&#xD;
      images, may better predict the clinical outcome of patients with sub-critical bifurcated&#xD;
      lesions managed conservatively.&#xD;
&#xD;
      Coronary angiography and OCT images will be combined to obtain a three-dimensional model of&#xD;
      the diseased coronary vessels that will be used to calculate the local blood flow patterns&#xD;
      and the time-averaged WSS at the bifurcated lesion level by using computational fluid&#xD;
      dynamics software.&#xD;
&#xD;
      Baseline (in patients both managed conservatively and treated by PCI) and post-PCI (in&#xD;
      patients treated by PCI) images will be processed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Target bifurcation failure (TBF)</measure>
    <time_frame>1,6,12,18,24 and 36 months</time_frame>
    <description>- Target bifurcated lesion-related major adverse coronary event (MACE) defined as the composite of:&#xD;
cardiac death&#xD;
myocardial infarction (MI) not clearly related with another vessel&#xD;
target vessel revascularization (TVR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure</measure>
    <time_frame>1,6,12,18,24 and 36 months</time_frame>
    <description>- In the absence of target bifurcated lesion-related MACE, target bifurcated lesion angiographic failure defined, in patients treated by PCI, as: &gt; 50% restenosis on the main vessel (MV) or TIMI (Thrombolysis In Myocardial Infarction) flow &lt; 3 on the side branch (SB) at angiography eventually performed during the clinical course.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bifurcated lesion angiographic failure</measure>
    <time_frame>1,6,12,18,24 and 36 months</time_frame>
    <description>Cardiac death&#xD;
MI&#xD;
TVR&#xD;
Definite or probable stent thrombosis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Atherosclerosis, Coronary</condition>
  <arm_group>
    <arm_group_label>Cohort A</arm_group_label>
    <description>Patients with bifurcated coronary lesions treated by percutaneous coronary interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort B</arm_group_label>
    <description>Patients with untreated bifurcated coronary lesions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angiography and optical coherence tomography</intervention_name>
    <description>Coronary angiography and OCT images will be combined to obtain a three-dimensional model of the diseased coronary vessels that will be used to calculate the local blood flow patterns and the arterial time-averaged wall shear stress at the bifurcated lesion level</description>
    <arm_group_label>Cohort A</arm_group_label>
    <arm_group_label>Cohort B</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with stable or unstable coronary artery disease due to atherosclerosis involving a&#xD;
        major bifurcation site, who undergo diagnostic or interventional invasive percutaneous&#xD;
        coronary procedures with the use of optical coherence tomography (OCT) based on operator's&#xD;
        choice.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Patients with stable or unstable coronary artery disease;&#xD;
&#xD;
          -  TIMI 3 on both MV and SB;&#xD;
&#xD;
          -  MV visual diameter &gt; 2.5 mm;&#xD;
&#xD;
          -  SB visual diameter &gt; 2.0 mm;&#xD;
&#xD;
          -  Documentation of angiographically-critical (visually estimated percentage diameter&#xD;
             stenosis ≥80% &lt;100%) coronary lesion treated by PCI and underwent post-PCI OCT&#xD;
             assessment or angiographically-intermediate (visually estimated percentage diameter&#xD;
             stenosis ranging between 30-80%) lesion in the MV considered suitable for conservative&#xD;
             management (myocardial revascularization not planned).&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Age &lt; 18 years or impossibility to give informed consent.&#xD;
&#xD;
          -  Female sex with child-bearing potential.&#xD;
&#xD;
          -  Life expectancy of less than 12 months or factors making clinical follow-up difficult&#xD;
             (no fixed address, etc.).&#xD;
&#xD;
          -  Ascertained or suspected contraindications to prolonged (up to 6 month) double&#xD;
             antiplatelet therapy.&#xD;
&#xD;
          -  Known hypersensitivity to aspirin, heparin, contrast dye, sirolimus, everolimus,&#xD;
             zotarolimus, cobalt, chromium, nickel, tungsten acrylic, and fluoro-polymers.&#xD;
&#xD;
          -  Poor cardiac function as defined by left ventricular global ejection fraction ≤ 30%.&#xD;
&#xD;
          -  Recent (&lt; 48 hours) ST-segment elevation myocardial infarction.&#xD;
&#xD;
          -  Severe myocardial hypertrophy (interventricular septum thickness &gt; 15 mm, ECG&#xD;
             Sokolow's criteria fulfilled).&#xD;
&#xD;
          -  Severe valvular heart disease.&#xD;
&#xD;
          -  Significant platelet count alteration (&lt;100,000 cells/mm3 or &gt; 700,000 cells/mm3).&#xD;
&#xD;
          -  Gastrointestinal bleeding requiring surgery or blood transfusions within 4 previous&#xD;
             weeks.&#xD;
&#xD;
          -  History of clotting pathology.&#xD;
&#xD;
          -  Advance renal failure with glomerular filtration rate &lt; 30 ml/min (Cockcroft-Gault&#xD;
             equation)&#xD;
&#xD;
          -  Left main lesion.&#xD;
&#xD;
          -  Target bifurcation located on a distal coronary segment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Burzotta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico A. Gemelli. Università Cattolica del Sacro Cuore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Burzotta, MD</last_name>
    <phone>+39 3494295290</phone>
    <email>francesco.burzotta@unicatt.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico A. Gemelli. Università Cattolica del Sacro Cuore</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Francesco Burzotta, MD, PhD</last_name>
      <phone>+39 349-429-5290</phone>
      <email>francesco.burzotta@unicatt.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>May 30, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2017</study_first_posted>
  <last_update_submitted>May 30, 2017</last_update_submitted>
  <last_update_submitted_qc>May 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Francesco Burzotta</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Optical coherence tomography</keyword>
  <keyword>Percutaneous coronary interventions</keyword>
  <keyword>Coronary atherosclerosis in bifurcations</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

